Skip Navigation
Menu
Ideas and Opinions |17 February 2015

Clinical Trial Data Sharing: What Do We Do Now?

Steven N. Goodman, MD, MHS, PhD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published online first at www.annals.org on 27 January 2015.
  • From Stanford University, Stanford, California.

    Acknowledgment: Dr. Goodman is a member of the committee that wrote the Institute of Medicine report.

    Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-0021.

    Requests for Single Reprints: Steven N. Goodman, MD, MHS, PhD, Stanford University, 259 Campus Drive, HRP/Redwood Building T265, Stanford, CA 94305; e-mail, steve.goodman@stanford.edu.

    Author Contributions: Conception and design: S.N. Goodman.

    Drafting of the article: S.N. Goodman.

    Critical revision of the article for important intellectual content: S.N. Goodman.

    Final approval of the article: S.N. Goodman.

×
FULL TEXT
Looking troubled amidst the hubbub of a successful election night, Robert Redford's title character in the 1972 movie The Candidate asks, “What do we do now?” We must ask the same question about clinical trial data sharing. Although the campaign for such sharing has effectively been won—with support expressed by government agencies, funders, research groups, journals, patient groups, and industry—data sharing is hardly routine (1). Maximizing its benefits and minimizing its risks remain a technical, procedural, and political challenge. This motivated the formation of the Institute of Medicine committee on Strategies for Responsible Sharing of Clinical Trial Data to outline principles and policies that should govern the sharing of data from clinical trials.
In this issue, Rosenblatt and colleagues (2) describe some of the risks of data sharing from the perspective of industry, including the dissemination of incorrect or misleading analyses and issues of patient confidentiality and consent. They express hope that the Institute of Medicine committee will address these risks, in concert with the benefits, in a balanced manner. The committee's report was released in January 2015 by members representing such diverse sectors as patient advocacy, academia, and industry (3). The risks and benefits outlined in the report include those described by Rosenblatt and colleagues.
The report's suggested timelines for sharing may get the most attention. The recommended maximum delay for data release is 6 months after primary publication for the data underlying a paper's analyses and 18 months after trial termination for...
FULL TEXT
PDF
Not Available
Citations
Citation

Goodman SN. Clinical Trial Data Sharing: What Do We Do Now?. Ann Intern Med. 2015;162:308–309. doi: https://doi.org/10.7326/M15-0021

Download citation file:

© 2020

×
Permissions

Published: Ann Intern Med. 2015;162(4):308-309.

DOI: 10.7326/M15-0021

3 Citations

Related Articles
Rethinking the Use of Physicians as Hired Expert Lecturers
Annals of Internal Medicine; 161 (5): 363-364
Introduction
Annals of Internal Medicine; 127 (8_Part_2): 665
Reflections on Medical Journals: Has Progress Made Them Better?
Annals of Internal Medicine; 137 (1): 46-48
A Registry for Clinical Trials
Annals of Internal Medicine; 128 (8): 701-702
View MoreView Less

Journal Club
Review: Neuraminidase inhibitors reduce symptomatic influenza; oseltamivir does not reduce hospitalizations
Annals of Internal Medicine; 161 (8): JC2
View MoreView Less

Related Topics
Ethics
Healthcare Delivery and Policy

Ethics, Healthcare Delivery and Policy.

PubMed Articles
Update of Guidelines for Management of Prostate Cancer in West Africa 2019: Consensus Working Document.
West Afr J Med ;37(2):159-172.
The epidemiology of Hepatitis B, C and D in Germany: A scoping review.
PLoS One 2020;15(3):e0229166.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×